These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 18687339)

  • 1. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein.
    Jain S; Udgaonkar JB
    J Mol Biol; 2008 Oct; 382(5):1228-41. PubMed ID: 18687339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salt-induced modulation of the pathway of amyloid fibril formation by the mouse prion protein.
    Jain S; Udgaonkar JB
    Biochemistry; 2010 Sep; 49(35):7615-24. PubMed ID: 20712298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the pathway of worm-like amyloid fibril formation by the mouse prion protein by delineation of the productive and unproductive oligomerization reactions.
    Jain S; Udgaonkar JB
    Biochemistry; 2011 Feb; 50(7):1153-61. PubMed ID: 21214263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
    Kumar S; Mohanty SK; Udgaonkar JB
    J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
    Ladner-Keay CL; Griffith BJ; Wishart DS
    PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the structural core and of conformational heterogeneity during the conversion of oligomers of the mouse prion protein to worm-like amyloid fibrils.
    Singh J; Sabareesan AT; Mathew MK; Udgaonkar JB
    J Mol Biol; 2012 Oct; 423(2):217-31. PubMed ID: 22789566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pathogenic Mutation T182A Converts the Prion Protein into a Molten Globule-like Conformation Whose Misfolding to Oligomers but Not to Fibrils Is Drastically Accelerated.
    Singh J; Udgaonkar JB
    Biochemistry; 2016 Jan; 55(3):459-69. PubMed ID: 26713717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
    Yamaguchi K; Matsumoto T; Kuwata K
    Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nearly reversible conformational change of amyloid fibrils as revealed by pH-jump experiments.
    Yamaguchi K; Kamatari YO; Fukuoka M; Miyaji R; Kuwata K
    Biochemistry; 2013 Oct; 52(39):6797-806. PubMed ID: 24000807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid formation via supramolecular peptide assemblies.
    Moore RA; Hayes SF; Fischer ER; Priola SA
    Biochemistry; 2007 Jun; 46(24):7079-87. PubMed ID: 17521170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers.
    Vendrely C; Valadié H; Bednarova L; Cardin L; Pasdeloup M; Cappadoro J; Bednar J; Rinaudo M; Jamin M
    Biochim Biophys Acta; 2005 Aug; 1724(3):355-66. PubMed ID: 15975719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of amyloid fibrils from β-amylase.
    Luo JC; Wang SC; Jian WB; Chen CH; Tang JL; Lee CI
    FEBS Lett; 2012 Mar; 586(6):680-5. PubMed ID: 22449963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH.
    Yamamoto S; Hasegawa K; Yamaguchi I; Tsutsumi S; Kardos J; Goto Y; Gejyo F; Naiki H
    Biochemistry; 2004 Aug; 43(34):11075-82. PubMed ID: 15323566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation.
    Kumar S; Udgaonkar JB
    J Mol Biol; 2009 Jan; 385(4):1266-76. PubMed ID: 19063899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.